Citigroup Inc Crispr Therapeutics Ag Transaction History

Citigroup Inc

$153 Billion
Q2 2024

A detailed history of Citigroup Inc transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Citigroup Inc holds 38,104 shares of CRSP stock, worth $1.97 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

38,104

Previous 101,469 62.45%

Holding current value

$1.97 Million

Previous $6.92 Million 70.26%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$51.17 - $68.18 $3.24 Million - $4.32 Million	-63,365 Reduced 62.45%	38,104 $2.06 Million
Q1 2024 May 10, 2024	SELL	$60.67 - $89.12 $583,402 - $856,977	-9,616 Reduced 8.66%	101,469 $6.92 Million
Q4 2023 Feb 09, 2024	SELL	$38.62 - $72.18 $39,624 - $74,056	-1,026 Reduced 0.92%	111,085 $6.95 Million
Q3 2023 Nov 09, 2023	BUY	$45.39 - $59.0 $164,175 - $213,403	3,617 Added 3.33%	112,111 $5.09 Million
Q2 2023 Aug 10, 2023	SELL	$43.47 - $67.77 $3.59 Million - $5.59 Million	-82,521 Reduced 43.2%	108,494 $6.09 Million
Q1 2023 May 11, 2023	BUY	$41.0 - $56.12 $2.71 Million - $3.71 Million	66,067 Added 52.88%	191,015 $8.64 Million
Q4 2022 Feb 09, 2023	BUY	$39.19 - $65.67 $327,393 - $548,607	8,354 Added 7.17%	124,948 $5.08 Million
Q3 2022 Nov 10, 2022	BUY	$61.1 - $83.78 $1.55 Million - $2.12 Million	25,340 Added 27.77%	116,594 $7.62 Million
Q2 2022 Aug 10, 2022	BUY	$43.23 - $73.83 $2.63 Million - $4.49 Million	60,876 Added 200.4%	91,254 $5.55 Million
Q1 2022 May 12, 2022	SELL	$53.19 - $79.24 $21,807 - $32,488	-410 Reduced 1.33%	30,378 $1.91 Million
Q4 2021 Feb 10, 2022	BUY	$70.09 - $111.29 $159,454 - $253,184	2,275 Added 7.98%	30,788 $2.33 Million
Q3 2021 Nov 10, 2021	BUY	$110.2 - $156.64 $3.14 Million - $4.47 Million	28,513 New	28,513 $3.19 Million

Others Institutions Holding CRSP

# of Institutions

503

Shares Held

57M

Call Options Held

1.7M

Put Options Held

1.8M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.03B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account